Qube Research & Technologies Ltd
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1729829
LONDON, X0
Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,153,655
-$10,967,817 QoQ
Shares Held
950,299
-21.0% QoQ
Ownership
0.555%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. ACAD ranks #26 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in ACAD
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,153,655 | 950,299 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,121,472 | 1,202,601 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,728,072 | 596,442 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,907,558 | 783,846 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,783,378 | 649,210 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,586,593 | 631,422 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,450,418 | 419,403 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $17,957,971 | 1,105,106 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,908,854 | 644,070 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,774,909 | 280,259 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,437,231 | 212,919 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $594,894 | 24,839 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $489,078 | 30,721 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $310,621 | 12,825 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $2,578,161 | 48,226 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $7,824,560 | 161,431 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||